Related Experiment Video
Updated: Feb 9, 2026

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages
Published on: June 30, 2016
Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage
Jingjing Tang1, Jeremy M Frey2, Carole L Wilson2
1Department of Pathology, University of Washington, Seattle, Washington, USA jjtang@uw.edu bornf@uw.edu.
Abstract:
Macrophages are prominent cells in acute and chronic inflammatory diseases. Recent studies highlight a role for macrophage proliferation post-monocyte recruitment under inflammatory conditions. Using an acute peritonitis model, we identify a significant defect in macrophage proliferation in mice lacking the leukocyte transmembrane protease ADAM17. The defect is associated with decreased levels of macrophage colony-stimulating factor 1 (CSF-1) in the peritoneum and is rescued by intraperitoneal injection of CSF-1. Cell surface CSF-1 (csCSF-1) is one of the substrates of ADAM17. We demonstrate that both infiltrated neutrophils and macrophages are major sources of csCSF-1. Furthermore, acute shedding of csCSF-1 following neutrophil extravasation is associated with elevated expression of iRhom2, a member of the rhomboid-like superfamily, which promotes ADAM17 maturation and trafficking to the neutrophil surface. Accordingly, deletion of hematopoietic iRhom2 is sufficient to prevent csCSF-1 release from neutrophils and macrophages and to prevent macrophage proliferation. In acute inflammation, csCSF-1 release and macrophage proliferation are self-limiting due to transient leukocyte recruitment and temporally restricted csCSF-1 expression. In chronic inflammation, such as atherosclerosis, the ADAM17-mediated lesional macrophage proliferative response is prolonged. Our results demonstrate a novel mechanism whereby ADAM17 promotes macrophage proliferation in states of acute and chronic inflammation.
Insights
The leukocyte protease ADAM17 is crucial for macrophage proliferation during inflammation by shedding cell surface CSF-1. Its absence impairs this process, highlighting a new therapeutic target for inflammatory diseases.
Area of Science:
- Immunology
- Cell Biology
- Inflammation Research
Background:
- Macrophages play key roles in acute and chronic inflammatory diseases.
- Macrophage proliferation following monocyte recruitment is increasingly recognized in inflammation.
Purpose of the Study:
- To investigate the role of the leukocyte protease ADAM17 in macrophage proliferation during inflammation.
- To elucidate the mechanism by which ADAM17 influences macrophage proliferation.
Main Methods:
- Utilized an acute peritonitis mouse model to study macrophage proliferation.
- Assessed macrophage colony-stimulating factor 1 (CSF-1) levels and ADAM17 activity.
- Investigated the role of iRhom2 in ADAM17 function and CSF-1 shedding.
Main Results:
- Mice lacking ADAM17 exhibited a significant defect in macrophage proliferation.
- This defect was linked to reduced peritoneal CSF-1, which was rescued by CSF-1 administration.
- ADAM17 cleaves cell surface CSF-1 (csCSF-1), with neutrophils and macrophages as major sources.
- iRhom2 regulates ADAM17-mediated csCSF-1 shedding from neutrophils and macrophages, impacting proliferation.
- ADAM17-mediated macrophage proliferation is transient in acute inflammation but prolonged in chronic conditions like atherosclerosis.
Conclusions:
- ADAM17 promotes macrophage proliferation in both acute and chronic inflammatory settings.
- The study reveals a novel mechanism involving ADAM17-mediated csCSF-1 shedding that regulates macrophage expansion.
- This pathway represents a potential therapeutic target for modulating inflammatory responses.
Related Concept Videos
Inflammation
Cells Coordinate Growth and Proliferation
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Cell-surface Signaling
Abnormal Proliferation
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...

